Clinical Trial Update: A Clinical Study on the Evaluation of BD114 for the Treatment HPV-16-Related Cervical HSIL [NA]

View source ↗

Summary

A clinical study evaluating BD114 for HPV-16–related cervical HSIL is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• BD114

Snippet

Sponsor: Shanghai BDgene Co., Ltd. | Conditions: High-grade Squamous Intraepithelial Lesions (HSIL) | NA | Status: RECRUITING